Reporting and Publication of Postmarket Clinical Trials for Novel Drugs Approved by the FDA
This cross-sectional study describes methods and timing of dissemination of the results of efficacy and safety trials outlined in postmarketing requirements for novel drugs approved by the US Food and Drug Administration (FDA).
Authors
- Maximilian Siebert (ORCID: https://orcid.org/0000-0003-4385-5773)
- Florence T. Bourgeois
- Joshua D. Wallach
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- Emory University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-07-23
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.24832
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00